Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma
Open Access
- 31 May 2005
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (5), 728-735
- https://doi.org/10.1016/j.jhep.2004.12.037
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Endocrine Aspects of Cancer Gene TherapyEndocrine Reviews, 2004
- Gene therapy of neoplastic liver diseasesThe International Journal of Biochemistry & Cell Biology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Hepatocellular carcinomaJournal of Hepatology, 2000
- Hepatocellular carcinomaThe Lancet, 1999
- Hepatocellular carcinomaBritish Journal of Surgery, 1998
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cellsCancer Letters, 1995
- Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.Proceedings of the National Academy of Sciences, 1994
- Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proceedings of the National Academy of Sciences, 1993